This message was sent to ##Email##
|
|
|
|
|
| |
| HEALTH CARE NEWS AND UPDATES |
NCBD
Over the years, the Commission on Cancer (CoC) has received valuable feedback to improve the data collected by the National Cancer Database (NCDB), which directly impacts the patients we all serve. The CoC acknowledges the magnitude of the 2018 changes, which seem overwhelming especially with the unexpected delay in the release of the tools and references that facilitate the task of abstraction including the Standards for Oncology Registry Entry (STORE) effective for cases diagnosed Jan. 1, 2018 and later. The CoC recognizes the challenges faced by our dedicated hospital registrars who continue to work tirelessly to ensure timeliness and accuracy of recording data; however, it is also part of the CoC’s commitment to provide clear and up-to-date instructions based on the collaborative effort of the experts involved in the development of the STORE. While all suggestions could not be implemented immediately with the current version of the STORE, significant changes have been made. For any other questions or concerns, please contact the NCDB at ncdb@facs.org.
The NCDB would not exist without the efforts of cancer registrars across the nation, and the CoC thanks the registrars at all CoC-accredited programs for their perseverance and patience during these difficult, but necessary, times of change.
READ MORE
|
Promoted by
|
|
|
|
 |
Reuters
Many U.S. doctors don’t discuss the harms of lung cancer screening or the potential for overdiagnosis in conversations with current and former smokers about whether tests are necessary, two new studies suggest.
The U.S. Preventive Services Task Force (USPSTF) recommends that doctors engage patients in shared decision making, with thorough discussions about the risk and benefits of screening, before patients get low-dose computed tomography (CT) scans (a form of high-powered X-ray) to look for any abnormalities on their lungs, researchers note in one of the studies in JAMA Internal Medicine.
READ MORE
Medical News Today
A new clinical trial shows the benefits of an innovative form of radiation therapy, which delivers the radiation in only five sessions instead of the usual 37. The National Cancer Institute estimates that prostate cancer affects more than 160,000 people in the United States. In 2018, almost 30,000 people will die from the disease.
As with most forms of cancer, treatment options range from surgery to radiation therapy, hormone therapy and chemotherapy.
READ MORE
 |
|
Our ihcDirect® method yields a revolutionary technology that opens a spectrum of new clinical applications including intraoperative surgery. Using the Novodiax PolyHRP technology, Intraoperative IHC tests can now be completed in just 10 minutes using fresh frozen tissues.
For more details, see our
 ihcDirect® product list.
|
|
Popular Mechanics
Three years ago, Jinghui Zhang, chair of the department of computational biology at St. Jude Children’s Research Hospital in Memphis, tried to download a set of 1,547 samples from a government database so she could run an experiment on it. The download took a year and a half. Every time Zhang’s team thought they had the complete set of data, they performed a statistical check that was supposed to catch any transmission errors. Seven times, the check failed. Seven times, the team started working only to realize that part of the set was missing, and they’d have to start all over. “Data downloading is a very painful process,” Zhang says. “It can potentially drive researchers away from science. Period.”
READ MORE
Medical Xpress
Biomarker-based risk profiling has the potential to improve lung cancer risk assessment, according to a study published online July 12 in JAMA Oncology. Florence Guida, PhD, from the International Agency for Research on Cancer in Lyon, France, and colleagues used samples from 108 ever-smoking patients with lung cancer diagnosed within a year of blood collection and samples from 216 smoking-matched controls to develop a lung cancer risk prediction model.
READ MORE
|
Promoted by
|
|
|
|
 |
Genetic Engineering & Biotechnology News
Validated diagnostic markers are key to the early detection and treatment of cancer. Moreover, if these biomarkers can be readily extracted and detected in bodily fluids, a simple, clinical diagnostic test can be developed that would be of extreme value to patients and physicians. For kidney cancer, investigators at Brigham and Women's Hospital and Beth-Israel Deaconess Medical Center believe they have found such a biomarker. In a new study, the researchers showed that kidney-injury-molecule-1 — which can be detected in the urine and blood — substantially helped distinguish between those who went on to develop kidney cancer from those who did not.
READ MORE
Oncology Nurse Advisor
For decades radiation oncology clinicians have noted rare instances of abscopal effects, in which tumors outside of a localized irradiated treatment field appear to respond to treatment. Counterintuitively, radiotherapy appears to stimulate some facets of the immune system, and recent research implicates patients' immune cells in radiation abscopal effects — raising the possibility that combining radiotherapy and immunotherapy could yield previously untapped treatment synergies to improve tumor control.
READ MORE
 |
|
Donate now to help Doctors Without Borders bring emergency medical care where it is needed most. Doctors Without Borders USA relies on unrestricted donations from private donors so when an emergency strikes we assess the needs and can act fast.
Donate today.
|
|
Medical Xpress
More than two-thirds of women with ovarian cancer have high-grade serous carcinoma (HGSC). Up to 90 percent of HGSCs are not detected until they are beyond the ovaries or fallopian tubes, at which point it may not be possible to fully remove the tumor. Many of these cancers are now known to originate in the fallopian tube, which is the site where almost all early HGSCs are discovered in healthy women undergoing resection of fallopian tubes. In contrast, among women who first come into the clinic with symptoms of advanced HGSC that has already spread beyond the gynecological region, clinicians can often find little or no evidence of malignancy in the fallopian tubes.
READ MORE
Archives of Pathology & Laboratory Medicine
The last decade has seen a complete transformation of the diagnostic and treatment landscape in the management of non–small cell lung cancer. Following the initial discovery of recurrent epidermal growth factor receptor mutations and then anaplastic lymphoma kinase translocations marking key subsets of NSCLCs highly responsive to targeted therapy, up-front reflex molecular testing has become requisite, impacting the workflow of pathology departments around the world in major ways and calling for careful tissue stewardship and close attention to proper triaging/processing/turnaround times.
READ MORE
 |
|
At the Association of Community Cancer Centers (ACCC) 35th National Oncology Conference in Phoenix, you’ll experience multidisciplinary strategies and groundbreaking processes to streamline operations, successfully engage patients, maximize staff productivity, improve clinician wellness, and more! Register by August 20
to save up to $125 off registration rates.
|
|
| ACS CANCER PROGRAMS UPDATES |
ACS
NAACCR is hosting a free webinar covering an update on the 2018 Implementation and Review of the Solid Tumor Rules from 2-3:30 p.m. ET, Aug. 30. One week prior to the live webinar, NAACCR will post case scenarios that will be discussed.
Register here. No CE hours will be associated with this webinar. A recording will be posted to the NAACCR 2018 Implementation page.
READ MORE
ACS
If you have a managerial background you'll be interested in the latest position opening within the Cancer Programs at The American College of Surgeons (ACS). This manager role is for the National Cancer Database Information and Data Standards (NCDB).
Do you have experience with:
- Managing a team
- CTR
- The NCDB Standards for Oncology Registry Entry (STORE) coding manual
- Managing agile data collection
This exciting position is located in the ACS Chicago office. In this role you will manage the NCDB data quality by evaluating quality of existing and incoming data, recommending changes in data collection procedures and registrar training, working with outside organizations to assure quality and continuity of data requirements and assisting with Cancer Programs training activities.
If you have incredible interpersonal skills, function well with multiple projects and tight deadlines, have a high level of energy and have a CTR certification we want you to apply!
To review this career opportunity in full detail and to apply click here.
ACS
The American College of Surgeons (ACS) 2018 Cancer Programs Annual Conference: Learn. Interact. Transform provides cutting-edge solutions to help you deliver high-quality, patient-centered, multidisciplinary care to patients with cancer. Through a combination of plenaries, breakout sessions and networking opportunities you will leave this conference reinvigorated and ready to overcome the challenges facing you as a cancer care provider.
Detailed information, as well as conference agenda, can be found on the Cancer Programs Annual Conference website.
Register now to take advantage of the early-bird registration fee and SAVE.
READ MORE
American College of Surgeons - NAPRC
The National Accreditation Program for Rectal Cancer (NAPRC) is now accepting applications. The NAPRC was developed to ensure that rectal cancer patients receive appropriate care following a multidisciplinary approach. Programs will be evaluated on the standards and metrics outlined in The National Accreditation Program for Rectal Cancer Standards Manual 2017 (revised October 2017).
READ MORE
Clinical Research Program
As mentioned in prior communications, the 2018 DCIS Special Study opened July 16. We invite you to visit the 2018 Special Study on DCIS SharePoint site, which will house all materials you will need to participate in the study. We have created a universal login for this site; please note it is case sensitive:
Login: DCISStudy
Password: study2018.
All registrars and co-registrars will be able to access and download materials via the SharePoint site.
READ MORE
ACS
The AJCC Cancer Staging Manual is the gold standard to help the cancer patient management team determine the correct stage for patients, allowing for the most appropriate care plan.
The AJCC Cancer Staging Manual is used by physicians and health care professionals throughout the world to facilitate the uniform description and reporting of neoplastic diseases. Proper classification and staging of cancer is essential for the physician to assign proper treatment, evaluate results of management and clinical trials, and to serve as the standard for local, regional and international reporting on cancer incidence and outcome.
This corrected third printing includes the following features:
- Revised breast cancer staging system
- Revised histology codes in each chapter
- Corrected errata posted on www.cancerstaging.org through Feb. 2.
Special 25 percent discount! Expires Dec. 31.
Click here for the Springer order form.
READ MORE
| IMPORTANT DATES AND DEADLINES |
|
Missed last week's issue? See which articles your colleagues read most.
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
The Brief
Connect with AJCC
Connect with CoC
Connect with NAPBC
Recent Issues | Subscribe | Unsubscribe | Advertise | Web Version
Colby Horton, Vice President of Publishing, 469-420-2601 | Download media kit
Ashley Harrington, Senior Content Editor, 469-420-2642 | Contribute news
Disclaimer: The Brief is a digest of news selected for the Commission on Cancer (CoC) and the National Accreditation Program for Breast Centers (NAPBC), both quality programs of the American College of Surgeons, from thousands of sources by the editors of MultiBriefs, an independent organization that also manages and sells advertising. The Cancer Programs do not endorse any of the advertised products and services. Opinions expressed in the articles are those of the authors and not of the American College of Surgeons, and the Cancer Programs.
American College of Surgeons
633 N Saint Clair Street | Chicago, IL, 60611-3211 | 800-621-4111 | Contact Us
Learn how to add us to your safe sender list so our emails get to your inbox. |
|
| |
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
